ICON PLC Stock Price, News & Analysis

ICON plc (NASDAQ: ICLR) announced that CFO Brendan Brennan will present at two upcoming healthcare conferences. He will speak at the Wells Fargo 16th Annual Healthcare Conference on September 9, 2021, at 8:00 AM ET, and at the Baird Global Healthcare Conference on September 15, 2021, at 8:30 AM ET.

Investors can find updates on these events and links to live webcasts on the Investor section of ICON's website. As of June 30, 2021, ICON employed approximately 16,480 employees across 89 locations worldwide.

ICON plc (NASDAQ: ICLR) reported a strong Q2 2021, showcasing a record net business win of $1,106 million and a remarkable revenue increase of 40.5% year-over-year to $871 million. Adjusted EPS surged by 76.8% to $2.12. The acquisition of PRA is poised to enhance growth and shareholder value, with updated revenue guidance for 2021 between $5,300 million and $5,500 million. Cash generated from operations was $128.4 million, while net cash reached $707.2 million. Overall, the results highlight a robust financial position and positive outlook for the company.

ICON plc (NASDAQ: ICLR) successfully held its Annual General Meeting (AGM) on July 20, 2021, where all recommended resolutions were passed by shareholders. Key resolutions included re-election of directors, approval of financial reports, and authorizations for share allotment and market purchases. Approximately 45.4 million votes were cast. Notable outcomes were re-elections of Ciaran Murray, Joan Garahy, and Eugene McCague, alongside approvals for the fixing of auditors’ remuneration and disapplication of pre-emption rights. The company continues to emphasize growth and innovation in clinical research.

ICON plc (NASDAQ: ICLR) has completed its acquisition of PRA Health Sciences, forming a combined entity with 38,000 employees across 47 countries. The merger aims to create a leading healthcare intelligence and clinical research organization, enhancing clinical trials and accelerating drug development through advanced technology and diverse patient access. PRA shareholders received $80 in cash and 0.4125 shares of ICON stock. This strategic move positions ICON to improve biopharma customers' success in bringing essential medicines and devices to market.

ICON plc (NASDAQ: ICLR) announced the proposed acquisition of PRA Health Sciences, with the merger set to occur through ICON's wholly-owned subsidiary. The company plans to issue $500 million in Senior Secured Notes at 2.875% interest due 2026, replacing a previously planned offering of $1,515 million in 2028 notes due to an increase in credit facilities. The proceeds will fund the merger payment, refinance existing debt, and cover related expenses. The offering is expected to close on July 1, 2021, pending customary conditions.

ICON (NASDAQ: ICLR) announced the successful passing of all resolutions at its Extraordinary General Meeting held on June 15, 2021. Shareholders approved the issuance of ordinary shares related to the acquisition of PRA Health Sciences. The merger will see PRA operate as a subsidiary of ICON. Furthermore, PRA's stockholders also voted to adopt the Merger Agreement and approve executive compensation arrangements tied to the transaction. The merger is expected to close on July 1, 2021, pending any remaining conditions.

ICON plc (NASDAQ: ICLR) announced plans to acquire PRA Health Sciences via a merger, with a proposed offering of $2.015 billion in Senior Secured Notes. The funds will be used for cash consideration in the merger, refinancing existing debt, and covering related fees. The offering consists of $500 million of notes due 2026 and $1.515 billion due 2028, subject to market conditions. Successful completion of the merger depends on obtaining necessary approvals and satisfying closing conditions, which may present risks and uncertainties.

ICON plc (NASDAQ: ICLR), a leading global provider of outsourced drug and device development, announced key presentations at upcoming healthcare conferences. Mr. Brendan Brennan, CFO, will present at the Jefferies Virtual Healthcare Conference on June 1, 2021, at 08:00 AM ET. Dr. Steve Cutler, CEO, will present at the William Blair 41st Growth Stock Conference on June 2, 2021, at 11:40 AM ET. Live webcasts will be available on their Investor section. The company continues its strategic growth and service expansion in clinical development.

ICON plc (NASDAQ: ICLR), a leading global provider of outsourced drug and device development services, announced that CFO Brendan Brennan will present at two upcoming virtual healthcare conferences. The first presentation is scheduled for May 12, 2021, at the BofA Securities 2021 Virtual Healthcare Conference, followed by the UBS Virtual Global Healthcare Conference on May 24, 2021. For updates on these events, please check the Investor section of ICON's website. The company, headquartered in Dublin, employs approximately 16,070 staff across 89 locations globally.